Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Do Leadless Pacemakers After TAVR Offer Benefits?

The need for pacemaker after transcatheter aortic valve replacement (TAVR) remains slightly higher than with surgery, especially...
Dr. Carlos Fava -
Learn More
Structural heart disease

When to Perform Non-Cardiac Surgery After TAVR

Transcatheter aortic valve replacement (TAVR) is becoming increasingly common, not only in high-risk or inoperable patients but...
Dr. Carlos Fava -
Learn More
Structural heart disease

Tricuspid Edge-to-Edge Repair: One-Year Evolution

Tricuspid Edge-to-Edge Repair has emerged as a promising alternative to surgical repair. Different studies have shown it...
Dr. Carlos Fava -
Learn More
Structural heart disease

DIRECT TAVI: Is Predilation Important for Women?

Predilation was used in the early stages of TAVR to facilitate device advancing. However, the increasing operator...
Dr. Carlos Fava -
Learn More
Structural heart disease

Severe Aortic Stenosis in Bicuspids: Promising Self-Expanding Valve Outcomes at 3 years

Bicuspid aortic valves represent a significant challenge in TAVR because of its anatomical complexity and the presence...
Dr. Carlos Fava -
Learn More
Other

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known...
solaci -
Learn More
Structural heart disease

Evolution of Cardiac Damage in MitraClip

Degenerative mitral valve regurgitation affects the mitral apparatus and is related to severe insufficiency. At present, surgery...
solaci -
Learn More
Structural heart disease

Cardioband in Tricuspid Valve Regurgitation

Untreated tricuspid regurgitation (TR) has been associated to high morbimortality. Surgical treatment of isolated severe TR is...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy